+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07688928

Comparing the Safety and Effectiveness of Finerenone and Spironolactone for High Blood Pressure Caused by Primary Aldosteronism

Led by Bangladesh Medical University · Updated on 2026-07-07

104

Participants Needed

1

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the efficacy and safety of finerenone compared to spironolactone in treating hypertension caused by primary aldosteronism. This randomized, double-blind, active-controlled clinical trial will take place at the Endocrine Hypertension Clinic of the Department of Endocrinology, enrolling 104 adult patients with confirmed primary aldosteronism. Participants will be randomly assigned to receive either finerenone starting at 10 mg daily, titrated up to 40 mg daily or spironolactone 25-100 mg daily for 48 weeks. The study drugs will be adjusted to reach target blood pressure below 14090 mmHg and plasma renin concentration above 15 mUL. The primary outcome is the time and daily dose needed to reach these goals. Secondary outcomes include changes in blood pressure clinic and ambulatory, aldosterone and renin levels, kidney function, urinary albumin, heart muscle mass, and quality of life. Safety monitoring will focus on adverse events like high potassium and kidney function decline. During the trial, participants will undergo regular assessments including blood pressure measurements, blood tests for hormone levels and kidney function, and evaluations of heart and kidney health. Researchers will track medication doses and time needed to achieve target endpoints. Safety and side effects will be closely monitored throughout the 48 weeks. The study aims to provide important information about these treatments for managing hypertension due to primary aldosteronism.

CONDITIONS

Brief Title

Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary Aldosteronism

Research Team

S

Sharmin Jahan, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here